BioCentury
ARTICLE | Clinical News

Pollinex Quattro Ragweed: Phase II/III started

September 5, 2005 7:00 AM UTC

AGY began a double-blind, placebo-controlled, Canadian trial in about 240 subjects exposed to controlled quantities of ragweed pollen in an environmental exposure chamber (EEC). AGY's Pollinex-R ragwe...